Cheryl Lokanis, AUD | |
8301 161st Ave Ne, Suite 203, Redmond, WA 98052-3858 | |
(425) 882-4347 | |
Not Available |
Full Name | Cheryl Lokanis |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 27 Years |
Location | 8301 161st Ave Ne, Redmond, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598793853 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 021602 CD00002184 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Evergreen Speech And Hearing Clinic, Inc | 3577450931 | 5 |
News Archive
Behavior change and self-acceptance trump dieting hands-down when it comes to achieving long-term health improvements in obese women, according to a two-year study by nutrition researchers at the University of California, Davis.
Results released today from a survey of more than 900 women, who experienced sleep problems during menopause, shed light on the impact insomnia can have during this time in a woman's life. The survey also revealed that for many women, insomnia during menopause is not proactively addressed by their healthcare provider (HCP) and that often times, women don't communicate their symptoms to their HCP.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
Experts in magnetic resonance imaging (MRI) at the DZNE are optimizing the operation of MRI scanners as part of an international research effort to enable visualization of finer details of the human brain.
› Verified 6 days ago
Provider Name | Evergreen Speech And Hearing Clinic, Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1013934918 PECOS PAC ID: 3577450931 Enrollment ID: O20040301000872 |
News Archive
Behavior change and self-acceptance trump dieting hands-down when it comes to achieving long-term health improvements in obese women, according to a two-year study by nutrition researchers at the University of California, Davis.
Results released today from a survey of more than 900 women, who experienced sleep problems during menopause, shed light on the impact insomnia can have during this time in a woman's life. The survey also revealed that for many women, insomnia during menopause is not proactively addressed by their healthcare provider (HCP) and that often times, women don't communicate their symptoms to their HCP.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
Experts in magnetic resonance imaging (MRI) at the DZNE are optimizing the operation of MRI scanners as part of an international research effort to enable visualization of finer details of the human brain.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Cheryl Lokanis, AUD 8301 161st Ave Ne, Suite 203, Redmond, WA 98052-3858 Ph: (425) 882-4347 | Cheryl Lokanis, AUD 8301 161st Ave Ne, Suite 203, Redmond, WA 98052-3858 Ph: (425) 882-4347 |
News Archive
Behavior change and self-acceptance trump dieting hands-down when it comes to achieving long-term health improvements in obese women, according to a two-year study by nutrition researchers at the University of California, Davis.
Results released today from a survey of more than 900 women, who experienced sleep problems during menopause, shed light on the impact insomnia can have during this time in a woman's life. The survey also revealed that for many women, insomnia during menopause is not proactively addressed by their healthcare provider (HCP) and that often times, women don't communicate their symptoms to their HCP.
Regeneron Pharmaceuticals, Inc. today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Diabetic Macular Edema.
Experts in magnetic resonance imaging (MRI) at the DZNE are optimizing the operation of MRI scanners as part of an international research effort to enable visualization of finer details of the human brain.
› Verified 6 days ago
Evergreen Speech And Hearing Clinic, Inc Audiologist Medicare: Medicare Enrolled Practice Location: 8301 161st Ave Ne, #203, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043 | |
Carolyn M Anderson, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 15446 Bel Red Rd, Redmond, WA 98052 Phone: 425-883-5320 | |
Janie Marie Rodesiler, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 8301 161st Ave Ne Ste 208, Redmond, WA 98052 Phone: 425-882-4347 | |
Terence Limb, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8301 161st Ave Ne, Suite 203, Redmond, WA 98052 Phone: 425-260-2135 | |
Cornelia John, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8301 161st Ave Ne Ste 208, Redmond, WA 98052 Phone: 425-882-4347 | |
Christopher Thomas Norwood, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8301 161st Ave Ne Ste 208, Redmond, WA 98052 Phone: 425-882-4347 | |
Lindsey Melvin, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8301 161st Ave Ne Ste 203, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043 |